| DB ID | MyCo_6698 |
| Title | The clinical role of procalcitonin in hematopoietic SCT |
| Year | 2012 |
| PMID | 22343672 |
| Fungal Diseases involved | Fungal infection |
| Associated Medical Condition | Hematopoietic SCT |
| Genus | None |
| Species | None |
| Organism | None |
| Ethical Statement | This study was performed in accordance with the Helsinki Declaration and approved by the Ethics Committee of the University of Tokyo Hospital. |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | PCT |
| Biomarker Full Name | Procalcitonin |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Japan |
| Cohort | A total of 28 consecutive patients who underwent HSCT in our institution between September and December 2010 were included in the study. |
| Cohort No. | 28 |
| Age Group | None |
| P Value | p=0.447 |
| Sensitivity | None |
| Specificity | 1 |
| Positive Predictive Value | 1 |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | ELISA |
| Analysis Method | SphereLight-BRAHMS PCT immunoassay |
| ELISA kits | enzyme immunoassay Kit (Wako Pure Chemical Industries, Osaka, Japan) |
| Assay Data | None |
| Validation Techniques used | SphereLight-BRAHMS PCT immunoassay |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
| External Link | None |
